Modi and Putin meet on summit sidelines as India faces steep US tariff over Russian oil importsNew Foto - Modi and Putin meet on summit sidelines as India faces steep US tariff over Russian oil imports

TIANJIN, China (AP) — Indian Prime Minister Narendra Modi and Russian President Vladimir Putin met on the sidelines of a regional summit in China on Monday in a show of deepening ties whenNew Delhi's relations with Washington are strainedover the purchase of Russian oil. The two leaders held talks after attending the key session of theShanghai Cooperation Organizationgathering in the port city of Tianjin, where discussions focused on regional stability and bilateral cooperation. In his remarks to open the talks, Modi termed the partnership with Moscow as "special and privileged." Putin addressed Modi as a "dear friend" and hailed Russia's ties with India as special, friendly and trusting. "Russia and India have maintained special relations for decades. Friendly, trusting. This is the foundation for the development of our relations in the future," Putin said. "These relations are absolutely non-partisan in nature, supported by the overwhelming majority of the peoples of our countries." Modi usedthe meetingto welcome the peace initiatives aimed at halting the conflict between Russia and Ukraine and called on the stakeholders to move forward constructively. "To end the conflict soonest and establish peace permanently, we need to find out a way. It's a call of the entire humanity," Modi said. At the talks, Putin was accompanied by a large delegation that included top government officials. Russian state media reported that before sitting down for the formal dialouge, Putin and Modi spoke one-on-one for almost an hour in Aurus, a high-end, Russian-made limousine that Putin regularly brings on foreign trips. The meeting carried added significance as it came days after U.S.President Donald Trumpimposed an additional 25% tariffs on Indian imports, raising the total duties to a steep 50%, in retaliation to India's continued purchases of discounted Russian oil. Washington has repeatedly warned New Delhi against buying Russian crude which it said was partly keeping Moscow's revenues afloat to fund the Ukraine war. India has defended its imports as essential for meeting its growing energy needs of 1.4 billion people. Modi travelled to Russia twice last year. The first was a visit to Moscow for talks with Putin in July, which was his first trip to Russia since the full-scale invasion of Ukraine by the Kremlin's forces in February 2022. He then traveled to Kazan in October forthe summit of the BRICS blocof developing economies. Russia has hadstrong ties with India since the Cold War, and New Delhi's importance as a key trading partner has grown since the war between Moscow and Ukraine. China and India have become key buyers of Russian oil after the West shunned Russian exports to punish Moscow. India historically bought most of its crude from the Middle East, but the world's third-largest crude importer after China and the U.S. has started buying Russian oil available at discounted rates. Russia now accounts for around 37% of India's total oil imports, according to analysts and Indian officials. Trade between India and Russia has sharply increased in recent years, touching a record $68.7 billion in the 2024-25 financial year during strong energy cooperation. Imports from Russia reached around $64 billion and exports from India totaled about $5 billion, as per Indian government data. India's financial year runs from April to March. The two nations aspire to bolster the trade to $100 billion by 2030. ___ Roy reported from New Delhi.

Modi and Putin meet on summit sidelines as India faces steep US tariff over Russian oil imports

Modi and Putin meet on summit sidelines as India faces steep US tariff over Russian oil imports TIANJIN, China (AP) — Indian Prime Minister ...
Israel is committing genocide in Gaza, says scholars' associationNew Foto - Israel is committing genocide in Gaza, says scholars' association

THE HAGUE (Reuters) -The world's leading genocide scholars' association has passed a resolution saying that the legal criteria have been met to establish Israel is committing genocide in Gaza, its president said on Monday. Eighty-six percent of those who voted among the 500-member International Association of Genocide Scholars backed the resolution, which declares "Israel's policies and actions in Gaza meet the legal definition of genocide in Article II of the United Nations Convention for the Prevention and Punishment of the Crime of Genocide (1948)". There was no immediate response from the Israeli foreign ministry. Israel has in the past strongly denied that its actions in Gaza amount to genocide, and is fighting a case at the International Court of Justice in the Hague that accuses it of genocide. Israel launched its assault on the Gaza Strip in October, 2023, after fighters from Hamas, the Palestinian militant group in control of the territory, attacked Israeli communities, killing 1,200 people and capturing more than 250 hostages. Since then, Israel's military action has killed 63,000 people, damaged or destroyed most buildings in the territory and forced nearly all its residents to flee their homes at least once. Since its founding in 1994, the genocide scholars' association has passed nine resolutions recognising historic or ongoing episodes as genocides. (Reporting by Stephanie van den BergEditing by Hugh Lawson and Peter Graff)

Israel is committing genocide in Gaza, says scholars' association

Israel is committing genocide in Gaza, says scholars' association THE HAGUE (Reuters) -The world's leading genocide scholars' as...
Trump plans a hefty tax on imported drugs, risking higher prices and shortagesNew Foto - Trump plans a hefty tax on imported drugs, risking higher prices and shortages

WASHINGTON (AP) — PresidentDonald Trumphasplastered tariffson products from almost every country on earth. He's targeted specific imports including autos, steel and aluminum. But he isn't done yet. Trump has promised to impose heftytariffson pharmaceuticals, a category of products he's largely spared in his trade war. For decades, in fact, imported medicine has mostly been allowed to enter the United States duty free. That's starting to change. U.S. and European leaders recently detaileda trade dealthat includes a 15% tariff rate on some European goods brought into the United States, including pharmaceuticals. Trump is threatening duties of 200% more on drugs made elsewhere. "Shock and awe'' is how Maytee Pereira of the tax and consulting firm PwC describes Trump's plans for drugmakers. "This is an industry that's going from zero (tariffs) to the potentiality of 200%.'' Trump has promised Americans he'lllower their drug costs. But imposing stiff pharmaceutical tariffs risks the opposite and could disrupt complex supply chains, drive cheap foreign-made generic drugs out of the U.S. market and create shortages. "A tariff would hurt consumers most of all, as they would feel the inflationary effect ... directly when paying for prescriptions at the pharmacy and indirectly through higher insurance premiums,'' Diederik Stadig, a healthcare economist with the financial services firm ING, wrote in a commentary last month, adding that lower-income households and the elderly would feel the greatest impact. The threat comes as Trump also pressures drugmakers to lower prices in the United States. He recently sent letters to several companies telling them to develop a plan to start offering so-called most-favored nation pricing here. But Trump has said he'd delay the tariffs for a year or a year and a half, giving companies a chance to stockpile medicine and shift manufacturing to the United States — something some have already begun to do. Leerink Partners analyst David Risinger said in a July 29 note that most drugmakers have already increased drug product imports and may carry between six and 18 months of inventory in the U.S. Jefferies analyst David Windley said in a recent research note that tariffs that don't kick in until the back half of 2026 may not be felt until 2027 or 2028 due to stockpiling. Moreover, many analysts suspect Trump will settle for a tariff far lower than 200%. They also are waiting to see whether any tariff policy includes an exemption for certain products like low-margin generic drugs. Still, Stadig says, even a 25% levy would gradually raise U.S. drug prices by 10% to 14% as the stockpiles dwindle. In recent decades, drugmakers have moved many operations overseas – to take advantage of lower costs in China and India and tax breaks in Ireland and Switzerland. As a result, the U.S. trade deficit in medicinal and pharmaceutical products is big -- nearly $150 billion last year. The COVID-19 experience – when countries were desperate to hang onto their own medicine and medical supplies — underscored the dangers of relying on foreign countries in a crisis, especially when a key supplier is America's geopolitical rival China. In April, the administrationstarted investigatinghow importing drugs and pharmaceutical ingredients affects national security. Section 232 of the Trade Expansion Act of 1962 permits the president to order tariffs for the sake of national security. Marta Wosińska, a health policy analyst at the Brookings Institution, says there is a role for tariffs in securing U.S. medical supplies. The Biden administration, she noted,successfully taxed foreign syringeswhen cheap Chinese imports threatened to drive U.S. producers out of business. Trump has bigger ideas: He wants to bring pharmaceutical factories back to the United States, noting that U.S.-made drugs won't face his tariffs. Drugmakers are already investing in the United States. The Swiss drugmaker Roche said in April that itwill invest $50 billionin expanding its U.S. operations. Johnson & Johnson willspend $55 billion within the United Statesin the next four years. CEO Joaquin Duato said recently that the company aims to supply drugs for the U.S. market entirely from sites located there. But building a pharmaceutical factory in the United States from scratch is expensive and can take several years. And building in the U.S. wouldn't necessarily protect a drugmaker from Trump's tariffs, not if the taxes applied to imported ingredients used in the medicine. Jacob Jensen, trade policy analyst at the right-leaning American Action Forum, notes that "97% of antibiotics, 92% of antivirals and 83% of the most popular generic drugs contain at least one active ingredient that is manufactured abroad.'' "The only way to truly protect yourself from the tariffs would be to build the supply chain end to end in the United States,'' Pereira said. Brand-name drug companies have fat profit margins that provide flexibility to make investments and absorb costs as Trump's tariffs begin. Generic drug manufacturers do not. Some may decide to leave the U.S. market rather than pay tariffs. That could prove disruptive: Generics account for 92% of U.S. retail and mail-order pharmacy prescriptions. A production pause at a factory in Indiaa couple years agoled to a chemotherapy shortage that disrupted cancer care. "Those are not very resilient markets," Brookings' Wosińska said. "If there's a shock, it's hard for them to recover." She argues that tariffs alone are unlikely to persuade generic drug manufacturers to build U.S. factories: They'd probably need government financing. "In an ideal world, we would be making everything that's important only in the U.S.,'' Wosińska said. "But it costs a lot of money ... We have offshored so much of our supply chains because we want to have inexpensive drugs. If we want to reverse this, we would really have to redesign our system ... How much are we willing to spend?'' ___ Murphy reported from Indianapolis. AP Health Writer Matthew Perrone contributed to this report.

Trump plans a hefty tax on imported drugs, risking higher prices and shortages

Trump plans a hefty tax on imported drugs, risking higher prices and shortages WASHINGTON (AP) — PresidentDonald Trumphasplastered tariffson...
Son Heung-min says he 'let the fans down' after he fails to score, LAFC loses his hyped home debutNew Foto - Son Heung-min says he 'let the fans down' after he fails to score, LAFC loses his hyped home debut

LOS ANGELES (AP) — Son Heung-min was left frustrated and disappointed after his long-awaited home debut for Los Angeles FC ended witha 2-1 loss to San Diego FCon Sunday night. And while the South Korean superstar's legions of new and longtime fans didn't get to see a goal from their hero or a team victory at BMO Stadium, at least they got a glimpse of the tantalizing potential in Son's new team after it has a bit more time together. "I couldn't wait for this night, and then I feel like I let the fans down," Son said after his first defeat in four matches with LAFC. "But we've got to (keep) our heads up and accept this result. We move forward and we work hard, and we'll be back stronger than ever." Son finished with two shots on net and several strong attacking moments mostly after halftime during a tense meeting with Western Conference-leading San Diego in front of a raucous sellout crowd eager to welcome Los Angeles' next sporting superstar. The most agonizing moment was when Son hit the post with a screaming shot in the 78th minute. He also forced goalkeeper CJ Dos Santos to leave his feet make a save late in each half. But Son couldn't finish his chances, and his team couldn't rally in the second half after San Diego stars Hirving Lozano and Anders Dreyer erased the early lead created by Denis Bouanga's 15th-minute goal for LAFC. The result left LAFC 15 points behind expansion San Diego in fifth place in the conference standings, even though LAFC has three games in hand. Son has one goal and one assist in his four MLS matches,scoring on a beautiful free kicklast weekend at FC Dallas. LAFC recorded one win and two draws on the road this month, stoking Los Angeles' anticipation of the longtime Tottenham star's debut in his new home nearly four weeks afterLAFC announced the landmark signing. The crowd roared for Son from the moment he stepped on the field for warmups in Los Angeles, which has the world's largest Korean population outside Korea. With thousands of fans wearing his jerseys for club and country, Son repeatedly waved to those cheering him on, and he exhorted the crowd into a frenzy right before kickoff by pumping his arms. "I've been in amazing stadiums and experienced a lot, but today was very special," Son said. "I feel like the fans were amazing. That's why I'm more upset, because they deserved more today than one goal and zero points. They were fantastic. I can't wait to play at home again. It felt like really, really home, you know? They were welcoming me." After a slow first half broken up only by Bouanga's goal, LAFC finally got rolling. Son and Bouanga were active and dangerous in the second half, but repeatedly failed to cash in their numerous scoring chances. Son couldn't get a shot on target after a beautiful long pass from former Tottenham teammate Hugo Lloris in the 74th minute, and Bouanga was left in disbelief after he was unable to capitalize while alone against Dos Santos in the 82nd minute. LAFC coach Steve Cherundolo wasn't discouraged by his star forwards' inability to equalize, and he sees promising signs from their new partnership. "To be frank, it's been excellent," Cherundolo said. "We've had three away games and one home game, and we've created a lot of chances. Both of them are creating for each other, helping each other. ... We are definitely creating chances, and Sonny is helping us. We just need to be better at executing. Tonight, if you look at the stats, at (expected goals), the moments we had in front of goal, it's crazy that we walk away with nothing." Son jumped straight into LAFC's lineup after playing a full season for Tottenham, capped bya cathartic Europa League triumphand a summer tour in Asia in which he departed Spurs with an emotional farewell in Seoul. Son is leaving Los Angeles again for international duty this week, but he'll return with eight matches left in this exhausting year. "When I come back from the national team, we have probably two very important months, so we've got to push for that," Son said. "We're still very excited." ___ AP soccer:https://apnews.com/soccer

Son Heung-min says he 'let the fans down' after he fails to score, LAFC loses his hyped home debut

Son Heung-min says he 'let the fans down' after he fails to score, LAFC loses his hyped home debut LOS ANGELES (AP) — Son Heung-min ...
Coco Gauff and Naomi Osaka play each other at the US Open on MondayNew Foto - Coco Gauff and Naomi Osaka play each other at the US Open on Monday

NEW YORK (AP) —Coco Gauff and Naomi Osakaare scheduled to face each other inthe U.S. Open'sfourth round on Monday. Gauff, a 21-year-old from Florida, is the Grand Slam tournament's No. 3 seed.Osaka, a 27-year-old who was born in Japan and moved to the U.S. with her family at age 3, is the No. 23 seed. They have won a combined three titles at Flushing Meadows. Monday's winner will make it to this year's quarterfinals. Here is what you need to know about the most-anticipated match of the U.S. Open so far: When and where do Coco Gauff and Naomi Osaka play each other Monday? The match will be held in Arthur Ashe Stadium. The exact time it will start is uncertain; that will depend on how long the contest before theirs takes to finish. Gauff vs. Osaka is the second match in the tournament's biggest arena on Monday, after Andrey Rublev of Russia plays against Felix Auger-Aliassime of Canada in the fourth round of the men's bracket, starting at 11:30 a.m. EDT. So Gauff and Osaka could begin as early as 1:30 p.m. or perhaps closer to 2 or 3 p.m. — or maybe even later than that. There is just no way to know for sure. How can I watch Osaka vs. Gauff on TV? ESPN is showing the U.S. Open in the United States. Other countries' broadcasters arelisted here. How often have Coco Gauff and Naomi Osaka met head-to-head? This will be the sixth matchup between Gauff and Osaka as pros — and the second at Flushing Meadows. Back in 2019, also in Ashe,Osaka defeated a 15-year-old Gauff in straight sets, then consoled the teary American afterward and invited her to speak to the spectators. Gauff has won three of the four matches they have played against each other since then, so she leads the head-to-head series 3-2. How many Grand Slam titles have Osaka and Gauff won? Osaka owns four Grand Slam singles championships, including atthe U.S. Open in 2018 and 2020. The other two came at the Australian Open in 2019 and 2021. Gauff, who has beenworking with a new coach on her serveto try to overcome double-faulting problems, has collected two major trophies in singles — atthe U.S. Open in 2023and the French Open this year — and one in doubles. ___ Howard Fendrich has been the AP's tennis writer since 2002. Find his stories here:https://apnews.com/author/howard-fendrich. More AP tennis:https://apnews.com/hub/tennis

Coco Gauff and Naomi Osaka play each other at the US Open on Monday

Coco Gauff and Naomi Osaka play each other at the US Open on Monday NEW YORK (AP) —Coco Gauff and Naomi Osakaare scheduled to face each othe...

 

AB JRNL © 2015 | Distributed By My Blogger Themes | Designed By Templateism.com